New Key Statistics Module, Z-Score and F-Score
HKSE:01681 Key Ratios
Market Cap HK$ M | 4,823.18 |
Enterprise Value HK$ M | 1,336.85 |
P/E(ttm) | 5.19 |
PE Ratio without NRI | 5.14 |
Forward PE Ratio | 4.32 |
Price/Book | 1.17 |
Price/Sales | 1.59 |
Price/Free Cash Flow | 5.58 |
Price/Owner Earnings | 5.74 |
Payout Ratio % | 0.40 |
Revenue (TTM) HK$ M | 2,973.00 |
EPS (TTM) HK$ | 1.13 |
Beneish M-Score | -2.54 |
10-y EBITDA Growth Rate % | 14.30 |
5-y EBITDA Growth Rate % | 18.60 |
y-y EBITDA Growth Rate % | 12.20 |
EV-to-EBIT | 1.42 |
EV-to-EBITDA | 1.42 |
PEG | 0.28 |
Shares Outstanding M | 825.89 |
Net Margin (%) | 30.53 |
Operating Margin % | 32.39 |
Pre-tax Margin (%) | 33.59 |
Quick Ratio | 2.62 |
Current Ratio | 2.86 |
ROA % (ttm) | 16.04 |
ROE % (ttm) | 24.57 |
ROIC % (ttm) | 35.33 |
Dividend Yield % | 10.54 |
Altman Z-Score | 3.94 |
HKSE:01681 Number of Guru Trades
HKSE:01681 Volume of Guru Trades
Gurus Latest Trades with HKSE:01681
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:01681 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Consun Pharmaceutical Group Ltd Insider Transactions
No Available Data